Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(4): e36268, 2012.
Article in English | MEDLINE | ID: mdl-22558414

ABSTRACT

The benefits of long-term peritoneal dialysis (PD) in patients with end-stage renal failure are short-lived due to structural and functional changes in the peritoneal membrane. In this report, we provide evidence for the in vitro and in vivo participation of the renin-angiotensin-aldosterone system (RAAS) in the signaling pathway leading to peritoneal fibrosis during PD. Exposure to high-glucose PD fluids (PDFs) increases damage and fibrosis markers in both isolated rat peritoneal mesothelial cells and in the peritoneum of rats after chronic dialysis. In both cases, the addition of the RAAS inhibitor aliskiren markedly improved damage and fibrosis markers, and prevented functional modifications in the peritoneal transport, as measured by the peritoneal equilibrium test. These data suggest that inhibition of the RAAS may be a novel way to improve the efficacy of PD by preventing inflammation and fibrosis following peritoneal exposure to high-glucose PDFs.


Subject(s)
Amides/pharmacology , Cytoprotection/drug effects , Fumarates/pharmacology , Peritoneal Dialysis/adverse effects , Amides/therapeutic use , Animals , Biological Transport/drug effects , Biomarkers/metabolism , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Fibrosis , Fumarates/therapeutic use , Glucose/adverse effects , Inflammation/chemically induced , Inflammation/drug therapy , Male , Peritoneum/drug effects , Peritoneum/pathology , Rats , Rats, Sprague-Dawley , Renin-Angiotensin System/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...